BioPharma Dive January 16, 2026
A surge in deals and financings had the industry abuzz heading into this year’s J.P Morgan Healthcare Conference. But some aren’t sure if the rebound is here to stay.
SAN FRANCISCO — The irony isn’t lost on Alexis Borisy. The famed biotechnology investor has, all this week, at the industry’s biggest event, been taking meetings from a downtown hotel suite, on a glossy, powder blue couch that has an odd resemblance to a drug capsule. I guess it really does, he said with a booming laugh.
Borisy has co-founded handfuls of companies, including his current passion project, the venture capital firm Curie.Bio, and the cancer drugmaker Revolution Medicines, which is rumored to be in talks for a deal worth tens...
Today's Sponsors
Today's Sponsor